Autolus Therapeutics AUTL
NASDAQ AUTL
$2.24 -0.05 (-2.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Autolus Therapeutics (AUTL) Prepaid Assets (2017 - 2026)

Autolus Therapeutics' (AUTL) quarterly Prepaid Assets came in at $76.5 million in Q4 2025, up 13.58% YoY from $67.3 million in Q4 2024, and down 10.39% on a QoQ basis from $85.3 million in Q3 2025.

Analysis

Autolus Therapeutics (AUTL) Prepaid Assets (2017 - 2026) Analysis & Trends

Autolus Therapeutics (AUTL) has 9 years of Prepaid Assets data on file, last reported at $76.5 million in Q4 2025.

  • Quarterly Prepaid Assets rose 13.58% year-over-year to $76.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76.5 million (up 13.58% YoY) and the FY2025 annual result came in at $76.5 million, up 13.58% from the prior year.
  • Prepaid Assets slipped to $76.5 million in Q4 2025, from $85.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $85.3 million in Q3 2025 to a low of $35.0 million in Q4 2023.
  • A 5-year average of $54.1 million and a median of $51.0 million in 2023 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets decreased 24.01% — and 2024, when it surged 92.55%.
  • Tracing AUTL's Prepaid Assets over 5 years: stood at $36.3 million in 2021, then grew by 18.56% to $43.0 million in 2022, then slipped by 18.7% to $35.0 million in 2023, then soared by 92.55% to $67.3 million in 2024, then grew by 13.58% to $76.5 million in 2025.
  • The last three Prepaid Assets figures came in at $76.5 million (Q4 2025), $85.3 million (Q3 2025), and $67.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Autolus Therapeutics 594.86 Mn 393.23 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.14 Mn
Dec 31, 2025 76.47 Mn
Sep 30, 2025 85.34 Mn
Jun 30, 2025 67.88 Mn
Mar 31, 2025 68.78 Mn
Dec 31, 2024 67.33 Mn
Sep 30, 2024 59.58 Mn
Jun 30, 2024 51.64 Mn
Mar 31, 2024 44.75 Mn
Dec 31, 2023 34.97 Mn
Sep 30, 2023 51.53 Mn
Jun 30, 2023 47.53 Mn
Mar 31, 2023 50.53 Mn
Dec 31, 2022 43.01 Mn
Sep 30, 2022 48.94 Mn
Jun 30, 2022 42.20 Mn
Mar 31, 2022 40.57 Mn
Dec 31, 2021 36.28 Mn
Sep 30, 2021 64.41 Mn
Jun 30, 2021 52.94 Mn